Southwestern Comprehensive Sickle Cell Center

西南综合镰状细胞中心

• 批准号: 7636794
• 负责人: GEORGE R BUCHANAN
• 金额: $ 33.85万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-06-14 至 2012-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7636794
• 关键词: Southwestern; Comprehensive; Sickle; Cell; Center

DESCRIPTION (provided by applicant): The Southwestern Comprehensive Sickle Cell Center (the "Center"), which has served as one of the ten NHLBI-funded Centers during 2003-2008 grant cycle, is applying for continued support during the next funding cycle. The Center, based at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) and Children's Medical Center Dallas (CMCD), will continue to include other collaborating medical centers whose physicians and other personnel are dedicated to the care of persons with sickle cell disease and the conduct of novel clinical, translational, and health services research. These other Centers are the University of Texas at Dallas, the University of Oklahoma Health Sciences Center, the University of Texas Medical Branch at Galveston, and the University of Florida College of Medicine. The Center's track record during the current grant period in the CSCC Clinical Trials Consortium has been exemplary. Center investigators lead two of the five national clinical trials opened thus far and play prominent roles on Consortium committees. Moreover, clinical trial enrollment from the multiple sites in our Center has been substantial. The Center currently ranks second overall among the ten comprehensive centers in patient enrollment. The Center is also successfully executing basic science, clinical intra-Center, and a variety of other collaborative and institutional research protocols, accompanied by smoothly functioning administrative and patient services cores. The Center plans to continue and appreciably expand myriad research, patient care, education, and advocacy initiatives during the next five years. A cohesive, interactive, and collaborative spirit exists among Center investigators and their institutions, thus assuring the Southwestern Comprehensive Sickle Cell Center's continued success.

描述（由申请人提供）：西南综合镰状细胞中心（“中心”）在2003 - 2008年赠款周期中担任了十个NHLBI资助的中心之一，在下一个融资周期中申请持续支持。该中心位于德克萨斯大学西南医学中心（UT西南部）和达拉斯儿童医疗中心（CMCD），将继续包括其他合作的医疗中心，其医师和其他人员致力于镰状细胞疾病的护理以及新型临床，转化和医疗服务的行为。这些其他中心是得克萨斯大学达拉斯大学，俄克拉荷马大学健康科学中心，加尔维斯顿大学德克萨斯大学医学分支机构和佛罗里达大学医学院。该中心在CSCC临床试验联盟中当前赠款期间的往绩是典范。中心调查人员领导迄今为止五项国家临床试验中的两项，并在财团委员会中扮演着重要角色。此外，我们中心多个地点的临床试验入学率很高。该中心目前在患者入学率的十个综合中心中排名第二。该中心还成功地执行了基础科学，中心临床内部以及其他各种协作和机构研究方案，并伴随着顺利运作的行政和患者服务核心。该中心计划在未来五年内继续进行并明显扩大无数研究，患者护理，教育和倡导计划。中心调查员及其机构之间存在着凝聚力，互动和协作的精神，从而确保了西南综合镰状细胞中心的持续成功。